Forbes Mar 15, 2017 : Mike [Dr. Michael Yeadon, an ex chief of research at Pfizer] was told in the fall of 2010 that Pfizer was closing the Allergy & Respiratory diseases programs and his own role as the CSO of this group was being eliminated. Rather than seek employment elsewhere, Mike had others ideas.